VNDA icon

Vanda Pharmaceuticals
VNDA

Overview Fund Activity

140 hedge funds and large institutions have $672M invested in Vanda Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 57 increasing their positions, 31 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
140
Holders Change
+25
Holders Change %
+21.74%
% of All Funds
3.74%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
36
Increased
57
Reduced
31
Closed
11
Calls
$27M
Puts
$17.2M
Net Calls
+$9.75M
Net Calls Change
+$4.56M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$28M
2
OAM
2
Oxford Asset Management
United Kingdom
$16.7M
3
AL
3
AJO LP
Pennsylvania
$14.6M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$9.03M
5
BIM
5
Bogle Investment Management
Massachusetts
$8.8M

Top Sellers

1
DM
1
Deerfield Management
New York
$57.2M
2
Macquarie Group
2
Macquarie Group
Australia
$21.4M
3
PC
3
Paulson & Co
New York
$36.2M
4
SCM
4
Stonepine Capital Management
Oregon
$0
5
JGC
5
J. Goldman & Co
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Northwestern Mutual Wealth Management
151
Northwestern Mutual Wealth Management
Wisconsin
– -$7K -650 Closed
3 4 5 6
7